These findings suggested that the mRNA expression of LPAR2 was significantly higher in patients with HNSC than in patients in the control group (P < 0.01 and P < 0.001, respectively), irrespective of tumor grade, HPV expression status, nodal metastasis status, and mutation status (Fig. 7E, F, G, H.). Here, LPAR2 is linked to neoplasm.